-1.19 Fall Turns Biocryst Pharmaceuticals Inc (BCRX) Into A Losing Stock For Investors
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) has a beta value of 1.11 and has seen 3.22 million shares traded in the last trading session. The company, currently
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) has a beta value of 1.11 and has seen 3.22 million shares traded in the last trading session. The company, currently
In today’s recent session, 0.64 million shares of the Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) have been traded, and its beta is 1.08. Most recently the company’s
In the last trading session, 4.49 million Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) shares changed hands as the company’s beta touched 1.09. With the company’s per share
In last trading session, Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) saw 6.47 million shares changing hands with its beta currently measuring 1.07. Company’s recent per share price
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) has a beta value of 1.06 and has seen 5.56 million shares traded in the last trading session. The company, currently
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)’s traded shares stood at 4.79 million during the last session, with the company’s beta value hitting 1.08. At the close of
In the latest trading session,, 0.49 million Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) shares changed hands as the company’s beta touched 1.08. With the company’s most recent
© 2024, Powered by Smart TechOne